Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-11-14
1993-02-02
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514 53, 514572, 514946, A61K 3730
Patent
active
051838028
ABSTRACT:
Compositions for the treatment of osteoporosis and related diseases comprise calcitonin and, as an absorption enhancer, a glycyrrhizinate.
REFERENCES:
patent: 3988309 (1976-10-01), Matsuda et al.
patent: 4294829 (1981-10-01), Suzuki et al.
patent: 4304692 (1981-12-01), Hughes et al.
patent: 4393200 (1983-07-01), Miyashita et al.
patent: 4476116 (1984-10-01), Anik
patent: 4548922 (1985-10-01), Carey et al.
patent: 4597900 (1986-07-01), Arlowski et al.
Kondo et al. "Physiochemical properties and applications of .alpha.- & .beta.-glycyrrhizins, natural surface active agents in licorice root extract" CA 105(14):120456, 1986.
L. Illum, Archiv. For Pharmaci og Chemi, vol. 94, pp. 127-135, 1987.
K. Morimoto et al., J. Pharm. Pharmacol., 37, 134-136, 1985.
Derwent Abstract: 88-045809/07 of Japan 63002932A, published Jan. 7, 1988.
R. Ziegler, G. Holz, W. Steibl & F. Rave, Acta. Endocrinol., Supple (215), 54-55, 1978.
Derwent Abstract 85-320779/51 of Japan 60224616A published Oct. 9, 1985.
Derwent Abstract 85-246152/40 of Japan 60-161924A, published Aug. 23, 1985.
M. Mishima, W. Wakita, M. Nakano, Presentation at International Conference dated Apr. 2, 1987.
M. Mishima, Y. Wakita, M. Nakano, M. Hirota, S, Ikei, M. Akagi--Presentation at Conference Oct. 20-21, 1986.
S. Oakada, M. Mishima, M. Nakano, S. Ikei, M. Akagi, and S. Shibata--Japanese Pharmacological Meeting, Apr. 4, 1988.
M. Mishima et al., J. Pharmacobio-Dyn, 10, s-69 (1987).
S. Hirai, T. Yashiki and Mima, Int. J. Pharmaceutics 9, 165-172 and 173-184, (1981).
S. Hirai, et al., Diabetes, vol. 27, No. 3, p. 296, 1978.
Derwent Abstract 82491 D/45 of Japan 56122309, published Sep. 25, 1981.
Derwent Abstract 92092D/50 of Japan 56140924, published Nov. 4, 1981.
K. Morimoto et al., J. Pharm. Pharmacol. vol. 37, p. 759, 1985.
M. R. Gibson, Lloydia, vol. 41, No. 4, pp. 348-349 (1978).
E. Azaz & R. Segal, Pharm. Acta. Helv., 55, Nr. 6, pp. 183-186 (1980).
Chem. Abs. 84 : 155579d (1976) of A. Otsuka et al., Yakugaku Zasshi, 96(2), 203-8, (1976).
R. Segal, E. Touitou & S. Pisanty, Fourth Int. Conf. on Pharmaceutical Technology, Jun. 1986, Paris.
R. Segal and S. Pisanty, J. Clinical Pharmacy & Therapeutics 12, 165-171 (1987).
Derwent Abstract : 87-104723/15 of Japan 62051604, published Mar. 6, 1987.
Derwent Abstract : 83-773656 Japan 58140014A published Aug. 19, 1983.
Derwent Abstract 82-66899E Japan 57106612A published Jul. 12, 1982.
Aliverti Valerio
Dorigotti Luciano
Fonio Teodoro
Pinza Mario
Dinner Dara L.
ISF Societa per Azioni
Lentz Edward T.
Robinson Douglas W.
Venetianer Stephen
LandOfFree
Pharmaceutical compositions for intranasal administration of cal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for intranasal administration of cal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for intranasal administration of cal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-6939